China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen

NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab. https://scrip.citeline.com/SC150328/China-Biotech-CEO-Interview-Starting-A-CNS-Venture-In-An-Economic-Downturn Playlist: https://on.soundcloud.com/AaFyPUxfD2RiDEis5

Episode metadata supplied by the publisher feed · Published May 28, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen

0:00 45:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 45 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on May 28, 2024.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!